BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 17120591)

  • 1. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.
    Yu HH; Lee JH; Wang LC; Yang YH; Chiang BL
    Lupus; 2006; 15(10):651-7. PubMed ID: 17120591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
    Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
    J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical manifestations, laboratory test, treatment and outcome of neuropsychiatric involvement in pediatric systemic lupus erythematosus patients].
    Wu XY; Song HM; Zeng XF; He YY; Wang W; Li F; Guo YZ; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):286-90. PubMed ID: 19555568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].
    Lefèvre G; Zéphir H; Warembourg F; Michelin E; Pruvo JP; Hachulla E; Semah F; Dubucquoi S; Lenfant P; Vermersch P; Hatron PY; Prin L; Launay D
    Rev Med Interne; 2012 Sep; 33(9):491-502. PubMed ID: 22579860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause.
    Steup-Beekman GM; Zirkzee EJ; Cohen D; Gahrmann BM; Emmer BJ; Steens SC; Bollen EL; van Buchem MA; Huizinga TW
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii76-9. PubMed ID: 23253914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric involvement in systemic lupus erythematosus: A review.
    Carrión-Barberà I; Salman-Monte TC; Vílchez-Oya F; Monfort J
    Autoimmun Rev; 2021 Apr; 20(4):102780. PubMed ID: 33609799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study.
    Pinto B; Suresh SC; Ramyasri K; Narayan G; Susan D; Manuel S; Wodeyar A; Shivanna A; Janardana R; Chanakya K; Charles BS; Nanjundaswamy SK; Desai AM; Nadig R; Shobha V
    Lupus; 2022 Nov; 31(13):1563-1571. PubMed ID: 36134692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.
    Borowoy AM; Pope JE; Silverman E; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman D; Urowitz M; Zummer M; Hudson M; Tucker L; Peschken C
    Semin Arthritis Rheum; 2012 Oct; 42(2):179-85. PubMed ID: 22595642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
    Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
    Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.
    Meier AL; Bodmer NS; Wirth C; Bachmann LM; Ribi C; Pröbstel AK; Waeber D; Jelcic I; Steiner UC;
    Lupus; 2021 Sep; 30(10):1565-1576. PubMed ID: 34152246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus.
    Kasitanon N; Louthrenoo W; Piyasirisilp S; Sukitawu W; Wichainun R
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):179-85. PubMed ID: 12587842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.
    Padovan M; Castellino G; Bortoluzzi A; Caniatti L; Trotta F; Govoni M
    Rheumatol Int; 2012 Jan; 32(1):129-35. PubMed ID: 20676648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.